SCIENTIFIC REPORT

Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo

U H M Spandau¹, G Sauder¹, U Schubert³, H-P Hammes² and J B Jonas¹

¹ Department of Ophthalmology, Faculty of Clinical Medicine, Mannheim, Ruprecht-Karls-University of Heidelberg, Germany
² Department of Internal Medicine, Faculty of Clinical Medicine, Mannheim, Ruprecht-Karls-University of Heidelberg, Germany
³ Institute of Biochemistry, University of Giessen, Germany

Correspondence to:
Correspondence to:
Dr Ulrich Spandau
Augenklinik, Klinikum Mannheim, Theodor Kutzer Ufer 1–3, D-68167 Mannheim, Germany; Ulrich_Spandau{at}yahoo.de

Aim: To assess the effect of crystalline triamcinolone acetonide on retinal endothelial cell proliferation in vivo and in vitro.

Methods: For in vitro analysis, a sprouting assay was employed. Bovine retinal endothelial cells were stimulated with basic fibroblast growth factor (bFGF) and incubated with different concentrations of triamcinolone acetonide (0.05 mg/ml to 8 mg/ml). For in vivo analysis, a retinopathy of prematurity (ROP) model was used. 16 C57BL/J6 mice were exposed to 75% oxygen from postnatal day 7 to day 12. On day 12, triamcinolone acetonide was intravitreally injected into one eye ("study eye") and isotonic saline into the contralateral eye ("control eye"). On day 17, the mice were sacrificed and the eyes removed for quantitative analysis of preretinal neovascularisation. Four non-exposed mice served as negative control.

Results: The sprouting assay demonstrated a dose dependent inhibition of bovine retinal endothelial cell proliferation from 0.05 mg triamcinolone acetonide/ml (no inhibition) to 3 mg triamcinolone acetonide/ml (complete inhibition). Dosages of more than 2 mg/ml resulted in cytotoxic changes of endothelial cells. The ROP model demonstrated a significantly lower neovascular cell count of 58% in the study group compared to the control group (6.35 (SD 2.1) cells per histological section versus 14.9 (SD 5.3) cells; p<0.005).

Conclusions: Triamcinolone acetonide inhibits bFGF induced proliferation of retinal endothelial cells in vivo and in vitro. These findings contribute to understanding the mode of action and effects of triamcinolone acetonide on retinal neovascularisation.

Abbreviations: ARMD, age related macular degeneration; bFGF, basic fibroblast growth factor; BRECs, bovine retinal endothelial cells; ECGS, endothelial cell growth supplement; FCS, fetal calf serum; MC, microcarrier; PBS, phosphate buffered saline; ROP, retinopathy of prematurity; TA, triamcinolone acetonide; VEGF, vascular endothelial growth factor

Keywords: triamcinolone acetonide; retinal endothelial cells

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Tatar, O., Adam, A., Shinoda, K., Kaiserling, E., Boeyden, V., Claes, C., Eckardt, C., Eckert, T., Pertile, G., Scharioth, G. B., Yoeruek, E., Szurman, P., Bartz-Schmidt, K. U., Grisanti, S. (2009). Early Effects of Intravitreal Triamcinolone Acetonide on Inflammation and Proliferation in Human Choroidal Neovascularization. Arch Ophthalmol 127: 275-281 [Abstract] [Full Text]  
• Sato, T, Kusaka, S, Hashida, N, Saishin, Y, Fujikado, T, Tano, Y (2009). Comprehensive gene-expression profile in murine oxygen-induced retinopathy. Br. J. Ophthalmol. 93: 96-103 [Abstract] [Full Text]  
• Jonas, J. B (2007). Effects of triamcinolone acetonide injections with and without preservative. Br. J. Ophthalmol. 91: 1099-1101 [Full Text]  
• Hartnett, M. E., Martiniuk, D. J., Saito, Y., Geisen, P., Peterson, L. J., McColm, J. R. (2006). Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy. IOVS 47: 4975-4982 [Abstract] [Full Text]